Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.30 |
| ▸ | CD44 | P16070 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19858987 | 0.86 | TRPA1 (0.42) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL28428912 | 0.86 | CYP1A2 (0.30) | CYP2A6CYP1A2 | |
| SCHEMBL22833975 | 0.77 | ERN1 (0.32) | ALDH1A1 | |
| SCHEMBL3410995 | 0.77 | ERN1 (0.32) | ALDH1A1 | |
| SCHEMBL1573210 | 0.76 | CA1 (0.42) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL168886 | 0.76 | ESR1 (0.45) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL6619213 | 0.75 | CYP1A2 (0.46) | ALDH1A1TSHRCYP2A6CYP1A2TDP1 | |
| SCHEMBL2572781 | 0.74 | CYP2A6 (0.33) | ALDH1A1CYP2A6 | |
| SCHEMBL14992458 | 0.74 | CYP3A4 (0.38) | ALDH1A1ACHETDP1ATM | |
| SCHEMBL14992136 | 0.74 | ALDH1A1 (0.33) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115448957-A | Novel tetradentate platinum complexes | 通用显示公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-111732611-B | Novel tetradentate platinum complexes | 通用显示公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-111732611-A | Novel tetradentate platinum complexes | 通用显示公司 | 2020-10-02 | — | — | CN | disclosed |
| CN-106749425-B | Novel tetradentate platinum complexes | 通用显示公司 | 2020-07-14 | — | — | CN | disclosed |
| US-10381580-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | disclosed |
| US-20180151816-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-31 | — | — | US | disclosed |
| US-20180151816-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-31 | — | — | US | disclosed |
| US-9947880-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-17 | — | — | US | disclosed |
| US-9947880-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-17 | — | — | US | disclosed |
| US-20150028323-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| US-20120223634-A1 | NOVEL TETRADENTATE PLATINUM COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-06 | — | — | US | disclosed |
| WO-2012116231-A2 | NOVEL TETRADENTATE PLATINUM COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-08-30 | — | — | WO | disclosed |
| US-8142909-B2 | Blue phosphorescent imidazophenanthridine materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-8142909-B2 | Blue phosphorescent imidazophenanthridine materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-8142909-B2 | Blue phosphorescent imidazophenanthridine materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| WO-2008156879-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008156879-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION | 2008-12-04 | — | — | US | disclosed |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION | 2008-12-04 | — | — | US | disclosed |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381580-B2 | Organic electroluminescent materials and devices | TEC, EML4, TPR | CA1 2272/4885CA2 1914/4885CA7 3357/4885 |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | IK, CRY1, MAP1LC3C | CA1 3204/4885CA2 621/4885CA7 1840/4885 |
| US-20180151816-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TEC, EML4, TPR | CA1 2272/4885CA2 1914/4885CA7 3357/4885 |
| US-20120223634-A1 | NOVEL TETRADENTATE PLATINUM COMPLEXES | PDCD1LG2, TEC, TPR | CA1 1636/4885CA2 1359/4885CA7 2564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.